Literature DB >> 88556

Salt intake and diuretic treatment of hypertension.

R F Bing, H Thurston, J D Swales.   

Abstract

24 h urinary sodium excretion was used to monitor salt intake in 36 patients with essential hypertension to determine whether limitation of the antihypertensive action of thiazide diuretics could be explained by increased salt appetitie stimulated by salt depletion. Sodium excretion in these patients was similar before treatment to that observed in normotensive controls, and no change was observed during 2 years' treatment with bendrofluazide. However, plasma-renin rose progressively over the 2 years even in 5 of 8 patients whose renin was not stimulated initially by diuretics. Thus, there is no evidence that a voluntary increase in salt intake limits the efficacy of diuretic treatment; on the other hand, progressive stimulation of the renin-angiotensin system may be an important limiting factor to the antihypertensive action of diuretics. If so, the antihypertensive effect of dietary salt restriction may be similarly limited.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 88556     DOI: 10.1016/s0140-6736(79)90004-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  4 in total

1.  The Renin-Angiotensin and Renal Dopaminergic Systems Interact in Normotensive Humans.

Authors:  Aruna R Natarajan; Gilbert M Eisner; Ines Armando; Shaunagh Browning; John C Pezzullo; Lauren Rhee; Mustafa Dajani; Robert M Carey; Pedro A Jose
Journal:  J Am Soc Nephrol       Date:  2015-05-14       Impact factor: 10.121

Review 2.  Do most antihypertensive agents have a sympatholytic action?

Authors:  J de Champlain
Journal:  Curr Hypertens Rep       Date:  2001-08       Impact factor: 5.369

3.  Dietary sodium and arterial pressure: problems of studies within a single population.

Authors:  G C Watt; C J Foy
Journal:  J Epidemiol Community Health       Date:  1982-09       Impact factor: 3.710

4.  Indapamide and bendrofluazide: a comparison in the management of essential hypertension.

Authors:  R F Bing; G I Russell; J D Swales; H Thurston
Journal:  Br J Clin Pharmacol       Date:  1981-12       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.